RISA Labs, a startup building an AI operating system for oncology, has raised $11.1 million in a Series A funding round led by Cencora Ventures and Optum Ventures.
The round also saw participation from Oncology Ventures, Z21 Ventures, and John Simon, the co-founder of General Catalyst, via Ventureforgood.
Founded by Kshitij Jaggi and Kumar Shivang, both IIT Kanpur graduates, RISA helps with patient access, benefits verification, and prior authorization using a team of AI agents, essentially automating complex workflows and saving invaluable time.
The newly raised funds will help speed up the deployment of RISA’s system to cancer clinics, health systems, specialty pharmacies, and infusion networks across the United States.
“In our vision for oncology, there are two sides to every patient’s journey: getting them on the right therapy faster and deepening our understanding of the disease for the next patient through data,” said CEO and co-founder Jaggi.
The Palo Alto, California-based startup said it was already live at some of the largest oncology practices in the US.
“Modern oncology has created thousands of potential care paths for every patient. It has become essential to have an intelligent operating system that can absorb this complexity, remove administrative burden, and act as a companion to the most informed clinical decisions,” said CTO Shivang.
Over the next year, the startup intends to build deeper partnerships in Oncology, together with ecosystem leaders, to expand AI-driven workflows across the full spectrum of cancer care.
“As the treatments available for oncology patients increase in number and complexity, solutions to help streamline operational processes and enable efficient access to therapy become vital. We look forward to supporting RISA on their next phase of growth,” said Jason Dinger, senior vice president, strategic execution at Cencora.
Last year, RISA Labs had raised $3.5 million in a seed round led by Flipkart co-founder Binny Bansal.
Leave a Reply